Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sonja Kary"'
Autor:
Sonja Kary
Publikováno v:
Gruppenpsychotherapie und Gruppendynamik. 58:63-68
Publikováno v:
The Journal of Rheumatology. 40:647-652
Objective.This posthoc analysis evaluated the percentage of patients with psoriatic arthritis (PsA) who achieved minimal disease activity (MDA) and compared the results with a modified MDA substituting the physician global assessment (PGA) for the Ps
Autor:
Jackie Shaw, Christoph Renner, Waji Hassan, Robert Landewé, Carmel B. Stober, Aruna S. Malipeddi, Karen Obrenovic, Paul Creamer, Ramesh N. Jois, Katilin DiGleria, Peter Lanyon, Y. Wang, Simon Kollnberger, Leticia Lojo-Oliveira, A. Baratelle, for Assert Go-Raise Investigators, Michele Olds, Claire Sheehy, D. van der Heijde, Michael J. Green, Lotta Utriainen, Charlotte Cavill, Frances Rees, Karen Mills, N. Kerrigan, J. S. Hill Gaston, Claudia Prevosto, M. Mack, J. Braun, Philip S. Helliwell, Sravan Payeli, P. Geusens, R. Inman, Lucy Coates, S. Xu, Sarah McDonald, Paul Bowness, S. Mudivarthy, Emilio Martín-Mola, Kaushik Sanyal, Gordon Taylor, Chandra Chattopadhyay, D. Gladman, A. Beutler, Tim Key, Philip J. Mease, Paul Emery, J. Sieper, Yasser El Miedany, Frederic Lavie, Jonathan Packham, Concepción Castillo-Gallego, B. Dijkmans, Joanna L. Giles, Rebecca Neame, Cynthia Wright, Benoit Guerette, Reyna Goodman, Alessandra De Riva, Ashok K. Bhalla, Miriam García-Arias, David G. I. Scott, M. U. Rahman, Osiris Marroquin, Roman Fischer, Helen Benham, Helen MakIver, Sarah Hailwood, Katsumi Maenaka, N. Goldstein, A Brooksby, Jon Packham, W. Xu, Christopher T. Ritchlin, Deborah Palmer, Ravinder Sandhu, A. Kavanaugh, Iain B. McInnes, Kirsty McHugh, William Tillett, Karl Gaffney, A. Deodhar, N. Vastesaeger, Michael J. Deery, J. Zrubek, Robert Busch, Jane C. Goodall, Neil McHugh, Sonja Kary, P. Mease, Philip G. Conaghan, Hartmut Kupper, G. G. Krueger, Chamaida Plasencia-Rodríguez, Eugenio de Miguel Mendieta, Gamal Ibrahim, Gill Peffers, James Francis, J. Leeder, Carolyn Bell, E. Korendowych, Benedikt M. Kessler, Louise Hamilton, Nicola Erb, Jacqueline Shaw, Margaret Somerville, Karen Walker-Bone, Simon Milling, Laura C. Coates, B. Hsu
Publikováno v:
Rheumatology. 50:iii137-iii145
Background: Sacroiliac joints (SJ) involvement is a distinctive and charasteristic feature of Spondyloarthritis (SpA) and x-ray is the test routinely used to make a diagnosis. However, x-ray reveals late structural damage but cannot detect active inf
Publikováno v:
Rheumatology. 49:1578-1589
OBJECTIVES To compare the clinical manifestations of spinal disease, peripheral arthritis and enthesitis, and to evaluate the effectiveness of adalimumab in a large cohort of patients with AS in relation to the presence or absence of psoriasis. METHO
Publikováno v:
Annals of the Rheumatic Diseases
Objective:To evaluate the effect of adalimumab on the frequency of anterior uveitis (AU) flares in patients with active ankylosing spondylitis (AS).Methods:We determined the history of ophthalmologist-diagnosed AU in 1250 patients with active AS who
Autor:
Xavier Mariette, Hartmut Kupper, Sonja Kary, Kristina Unnebrink, Gerd R Burmester, Francisco Navarro-Blasco, Marco Matucci-Cerinic
Publikováno v:
Arthritis Research and Therapy
Arthritis Research and Therapy, BioMed Central, 2014, 16 (1), pp.R24. ⟨10.1186/ar4452⟩
Arthritis Research & Therapy
Arthritis Research and Therapy, BioMed Central, 2014, 16 (1), pp.R24. ⟨10.1186/ar4452⟩
Arthritis Research & Therapy
International audience; INTRODUCTION: Patients with active rheumatoid arthritis who had failed at least one disease-modifying anti-rheumatic drug (DMARD) were treated with adalimumab (ADA) in the ReAct study with the option to continue treatment for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bdd5a50abd77525f11343f598e631fb
https://www.hal.inserm.fr/inserm-00949004/document
https://www.hal.inserm.fr/inserm-00949004/document
Autor:
Joachim Sieper, Maxime Breban, Fabrizio Cantini, Gino DiVittorio, Suchitrita S. Rathmann, Hartmut Kupper, Johan Bratt, Désirée van der Heijde, Phillip J. Mease, Aileen L. Pangan, Sonja Kary, Dale Halter
Publikováno v:
Rheumatology (Oxford, England)
Rheumatology, 54(7), 1210-1219
Rheumatology, 54(7), 1210-1219
Objective. Chronic pain and progressive loss of physical function with AS may adversely affect health-related quality of life (HRQoL). The objective of this study was to assess the 5-year data regarding spinal mobility, physical function and HRQoL in
Autor:
Andrea Kuhne, Angela Zink, H Sörensen, Norbert Ulbrich, Sonja Kary, Joachim Sieper, U. Eggens, Falk Hiepe, Werner Huge, Joachim Listing, Jürgen Braun, Nicholas Avrion Mitchison, Rieke Alten
Publikováno v:
Arthritis & Rheumatism. 39:41-51
Objective. To investigate the efficacy of oral type II collagen in the treatment of early rheumatoid arthritis (RA). Methods. Ninety patients with RA (disease duration ⩽3 years) were treated for 12 weeks with oral bovine type II collagen at 1 mg/da
Autor:
H. Kupper, M. Frank, Neil McHugh, E. Rodevand, P. Holck, Marjatta Leirisalo-Repo, B. Manger, R. van Vollenhoven, Martina Kron, Oliver FitzGerald, Philippe Goupille, F. Van den Bosch, Sonja Kary
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2010, 69 (2), pp.394-399
ANNALS OF THE RHEUMATIC DISEASES
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2010, 69 (2), pp.394-399
ANNALS OF THE RHEUMATIC DISEASES
Objectives:To evaluate the effectiveness of adalimumab in patients with psoriatic arthritis (PsA) and identify predictors of good clinical response for joint and skin lesions.Methods:Patients received adalimumab 40 mg every other week in addition to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9107ed70f9674d866046051473b2c53
https://hal.science/hal-00618632
https://hal.science/hal-00618632
Autor:
Martin Rudwaleit, Sonja Kary, Martina Kron, Hartmut Kupper, Eduardo Loza Cortina, Joachim Sieper, Pascal Claudepierre, Roberto Carcereri-De-Prati, Paul Wordsworth
Publikováno v:
The Journal of rheumatology. 36(4)
Objective.We evaluated the effectiveness and safety of adalimumab in a large cohort of patients with active ankylosing spondylitis (AS) and identified clinical predictors of good clinical response.Methods.Patients with active AS [Bath AS Disease Acti